# WuXi AppTec

Type: Company (2359.HK)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/wuxi-apptec
Canonical HTML page: https://getbiobrief.com/entity/wuxi-apptec

## Timeline

- **2026-03-07**: 15th FYP Announcement — China officially prioritizes tech self-reliance as the central pillar of the 2026-2030 plan.
- **2026**: Implementation Phase — Expected rollout of specific subsidies and domestic-first procurement policies.
- **2024**: Geopolitical Escalation — U.S. introduces Biosecure Act, targeting major Chinese biotech entities.
- **2021**: 14th Five-Year Plan — Initial focus on 'Dual Circulation' and building basic biotech infrastructure.

## Recent coverage (2 stories)

### Bachem Earnings Preview: Peptide Capacity and GLP-1 Demand in Focus
2026-03-11 07:27:04 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Bachem (BCHMF) is set to release its quarterly earnings this Thursday, with investors closely monitoring the Swiss CDMO's ability to scale production for the booming GLP-1 market. As a critical supplier of peptides and oligonucleotides, Bachem's financial performance and capacity expansion updates will serve as a bellwether for the broader weight-loss drug supply chain.
Full story: https://getbiobrief.com/story/bachem-earnings-preview-peptide-capacity-glp1-demand

### China Targets Biotech Autonomy in Strategic 15th Five-Year Plan
2026-03-07 15:42:14 · Sentiment: Neutral · Impact: 8/10 · Sources: 2

China has officially signaled a shift toward total technological self-reliance in its 15th Five-Year Plan, prioritizing the domestic life sciences and pharmaceutical sectors. This strategic pivot aims to insulate China’s healthcare infrastructure from global supply chain volatility and geopolitical pressures while fostering a homegrown innovation ecosystem.
Full story: https://getbiobrief.com/story/china-biotech-self-reliance-15th-five-year-plan

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.